SearchDictionaryMobileLogin

Gabriel N Hortobagyi Selected Research

Adjuvant Chemotherapy

10/2008Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.
06/2008Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
11/2007Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
06/2006Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
06/2004The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
05/2004Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.
07/2002Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
07/2002Adjuvant chemotherapy for breast cancer.
05/2002Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Articles by Research Topic

Disease

96Breast Neoplasms (Breast Cancer)
10/2008 - 01/2002
22Carcinoma (Carcinomatosis)
06/2007 - 05/2002
16Neoplasms (Cancer)
06/2008 - 06/2002
6Neoplasm Metastasis (Metastasis)
01/2008 - 08/2005
2Residual Neoplasm
07/2007 - 10/2006
2Lobular Carcinoma
12/2006 - 01/2005
2Male Breast Neoplasms (Male Breast Cancer)
07/2006 - 06/2002
1Obesity
09/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2008
1Osteonecrosis (Kienbock's Disease)
06/2008
1Phyllodes Tumor (Cystosarcoma Phylloides)
11/2007
1Heart Failure
09/2007
1Inflammation
08/2007
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007
1Ductal Carcinoma
12/2006
1Vasculitis (Vasculitides)
07/2006
1Death (Near-Death Experience)
03/2005
1Pneumonia (Pneumonitis)
11/2004
1Colitis
10/2004
1Neutropenia
01/2003
1Ovarian Neoplasms (Ovarian Cancer)
11/2002
1Pathologic Constriction (Stenosis)
06/2002

Drug/Important Bio-Agent (IBA)

13Paclitaxel (Taxol)FDA LinkGeneric
03/2008 - 05/2002
13Doxorubicin (Adriamycin)FDA LinkGeneric
11/2007 - 01/2002
9docetaxel (Taxotere)FDA Link
06/2008 - 01/2002
7trastuzumab (Herceptin)FDA Link
01/2007 - 04/2002
7Fluorouracil (Carac)FDA LinkGeneric
01/2007 - 01/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007 - 01/2002
6Biological Markers (Surrogate Marker)IBA
12/2006 - 06/2002
5Estrogens (Estrogen)FDA Link
10/2008 - 07/2003
4Epidermal Growth Factor Receptor (EGF Receptor)IBA
10/2007 - 06/2005
4taxaneIBA
08/2007 - 02/2002
3capecitabine (Xeloda)FDA Link
08/2007 - 09/2003
3Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 06/2005
2DiphosphonatesIBA
06/2008 - 05/2008
2erlotinib (CP 358,774)FDA Link
08/2007 - 06/2007
2HormonesIBA
05/2007 - 03/2005
2tau Proteins (tau Protein)IBA
04/2007 - 06/2005
2TamoxifenFDA LinkGeneric
07/2006 - 01/2002
2gemcitabineFDA Link
09/2003 - 05/2002
2vinorelbine (Navelbine)FDA LinkGeneric
05/2002 - 01/2002
25-ethynyluracil (eniluracil)IBA
05/2002 - 02/2002
1Lysine (L-Lysine)FDA Link
09/2008
1Histones (Histone)IBA
09/2008
1lapatinib (GW572016)FDA Link
07/2008
1Cisplatin (Platino)FDA LinkGeneric
05/2008
1Dacarbazine (DIC)FDA LinkGeneric
11/2007
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2007
1ixabepilone (BMS 247550)FDA Link
08/2007
1I-kappa B KinaseIBA
08/2007
1Cyclin-Dependent Kinase 2IBA
08/2007
1DNA (Deoxyribonucleic Acid)IBA
12/2006
1CyclinsIBA
10/2006
1Phosphotransferases (Kinase)IBA
10/2006
1temozolomide (Temodar)FDA Link
09/2006
1Aromatase (CYP19)IBA
07/2006
1Leuprolide (Lupron)FDA LinkGeneric
07/2006
1Cytosine DeaminaseIBA
01/2006
1EndostatinsIBA
01/2006
1Transcription Factors (Transcription Factor)IBA
12/2005
1ParaffinIBA
10/2005
1albumin-bound paclitaxelFDA Link
09/2005
1tariquidar (XR9576)IBA
08/2005
1P-GlycoproteinIBA
08/2005
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2005
1Carmustine (FIVB)FDA Link
11/2004
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2004
1TaxoidsIBA
07/2004
1Protein Kinases (Protein Kinase)IBA
02/2004
1Proteins (Proteins, Gene)IBA
01/2004
1fludarabineIBA
11/2003
1Melphalan (Alkeran)FDA Link
11/2003
1NF-kappa B (NF-kB)IBA
11/2003
1sulindac sulfone (exisulind)IBA
09/2003
1pegylated liposomal doxorubicinIBA
09/2003
1DX 8951 (DX 8951f)IBA
09/2003
1Filgrastim (Neupogen)FDA Link
07/2003
1RNA (Ribonucleic Acid)IBA
06/2003
1bexarotene (LGD1069)FDA Link
03/2003
1Estrogen ReceptorsIBA
03/2003
1Cyclin EIBA
11/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2002
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
11/2002
1annamycinIBA
07/2002
1anastrozole (Arimidex)FDA Link
06/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2002

Therapy/Procedure

55Drug Therapy (Chemotherapy)
09/2008 - 06/2002
9Adjuvant Chemotherapy
10/2008 - 05/2002
6Mastectomy (Mammectomy)
12/2006 - 07/2002
5Neoadjuvant Therapy
03/2008 - 06/2005
2Adjuvant Radiotherapy
10/2005 - 03/2005
1Biological Therapy
05/2007
1Hematopoietic Stem Cell Transplantation
11/2004
1Aftercare (After-Treatment)
02/2004
1Stem Cell Transplantation
11/2003
1Estrogen Replacement Therapy
11/2002